Medtronic plc
MDTFinancial Statements
Income Statement (Annual)
Amounts in millions
2025
4/30/2025
Revenue
33,537
Cost of Revenue
11,632
Gross Profit
21,905
Gross Margin
65.3%
Operating Income
5,955
Operating Margin
17.8%
Net Income
4,662
Net Margin
13.9%
EPS (Basic)
$3.63
EPS (Diluted)
$3.61
EBITDA
9,218
EBITDA Margin
27.5%
2024
4/30/2024
Revenue
32,364
Cost of Revenue
11,216
Gross Profit
21,148
Gross Margin
65.3%
Operating Income
5,144
Operating Margin
15.9%
Net Income
3,676
Net Margin
11.4%
EPS (Basic)
$2.77
EPS (Diluted)
$2.76
EBITDA
8,203
EBITDA Margin
25.3%
2023
4/30/2023
Revenue
31,227
Cost of Revenue
10,719
Gross Profit
20,508
Gross Margin
65.7%
Operating Income
5,485
Operating Margin
17.6%
Net Income
3,758
Net Margin
12.0%
EPS (Basic)
$2.83
EPS (Diluted)
$2.82
EBITDA
8,697
EBITDA Margin
27.9%
2022
4/30/2022
Revenue
31,686
Cost of Revenue
10,145
Gross Profit
21,541
Gross Margin
68.0%
Operating Income
5,752
Operating Margin
18.2%
Net Income
5,039
Net Margin
15.9%
EPS (Basic)
$3.75
EPS (Diluted)
$3.73
EBITDA
8,777
EBITDA Margin
27.7%
2021
4/30/2021
Revenue
30,117
Cost of Revenue
10,483
Gross Profit
19,634
Gross Margin
65.2%
Operating Income
4,484
Operating Margin
14.9%
Net Income
3,606
Net Margin
12.0%
EPS (Basic)
$2.68
EPS (Diluted)
$2.66
EBITDA
7,522
EBITDA Margin
25.0%